Re: Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial

Related Experiment Video

Updated: May 27, 2026

Acupoint Catgut Embedding for Treatment of Chronic Pelvic Pain Due to the Sequelae of Pelvic Inflammatory Disease
02:41

Acupoint Catgut Embedding for Treatment of Chronic Pelvic Pain Due to the Sequelae of Pelvic Inflammatory Disease

Published on: May 3, 2024

Richard E Berger

    The Journal of Urology
    |November 22, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
    08:33

    A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

    Published on: January 5, 2024

    Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis
    06:46

    Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis

    Published on: January 16, 2013

    Related Experiment Videos

    Last Updated: May 27, 2026

    Acupoint Catgut Embedding for Treatment of Chronic Pelvic Pain Due to the Sequelae of Pelvic Inflammatory Disease
    02:41

    Acupoint Catgut Embedding for Treatment of Chronic Pelvic Pain Due to the Sequelae of Pelvic Inflammatory Disease

    Published on: May 3, 2024

    A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
    08:33

    A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

    Published on: January 5, 2024

    Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis
    06:46

    Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis

    Published on: January 16, 2013

    Related Concept Videos

    Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

    Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

    Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
    These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

    Articles linked to this work by shared authors, journal, and citation graph.

    Priapism: comorbid factors and treatment outcomes in a contemporary series.

    Advances in urology·2012

    A pilot study of botulinum toxin A for male chronic pelvic pain syndrome.

    Scandinavian journal of urology and nephrology·2010

    A pilot study of botulinum toxin for interstitial cystitis/painful bladder syndrome.

    Neurourology and urodynamics·2010

    A review of botulinum toxin use for chronic pelvic pain syndrome.

    Current urology reports·2010

    Vasectomy by epithelial curettage without suture or cautery: a pilot study in humans.

    Asian journal of andrology·2010

    A Randomized Trial of Multimodal Prehabilitation Before Robotic-Assisted Radical Prostatectomy to Improve Postoperative Quality of Life and Functional Outcomes.

    The Journal of urology·2026

    Undescended Testes in Medically Complex Children: Evaluating A Common Urologic Condition Through a Multi-Disciplinary Lens.

    The Journal of urology·2026

    Initiation of Medical Therapy for Storage Lower Urinary Tract Symptoms After Benign Prostatic Hyperplasia Surgery.

    The Journal of urology·2026

    Male-First Evaluation Reduces Costs and Time to Pregnancy in Couples with a Varicocele: A Theoretical, Discrete-Time Markov Model.

    The Journal of urology·2026

    Anatomical Mapping of Lymphatic Leakage Leading to Symptomatic Lymphoceles Formation After Pelvic Lymph Node Dissection for Prostate Cancer.

    The Journal of urology·2026

    Causative factors and outcomes of pyogenic granulomas presenting to a hospital eye clinic.

    Clinical & experimental optometry·2026

    Meta-Analysis: Potassium-Competitive Acid Blockers Versus Proton Pump Inhibitors for Gastroprotection in Patients Receiving Antiplatelet Therapy.

    Alimentary pharmacology & therapeutics·2026

    Current practices, challenges, and future directions in subcutaneous oncology monoclonal antibody delivery: a qualitative study.

    Expert opinion on drug delivery·2026

    Ensuring patient rights, safety, and welfare in "compassionate use" of drugs.

    Perspectives in clinical research·2026

    Pediatric obesity pharmacotherapy: a practical guide for general pediatricians.

    Current opinion in pediatrics·2026

    Old Drugs, New Targets: Molecular Docking Insights into Repurposing Proton Pump Inhibitors for the TLR4/MD-2, NLRP3, and C5aR1 Axes in Autoimmune Liver Diseases.

    Pharmaceuticals (Basel, Switzerland)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us